Companion Animal Diagnostics Market Growth, Size, Trends Analysis - By Product, By Technology, By Application, By Animal, By End User - Regional Outlook, Competitive Strategies and Segment Forecast to 2034

Companion Animal Diagnostics Market Growth, Size, Trends Analysis - By Product, By Technology, By Application, By Animal, By End User - Regional Outlook, Competitive Strategies and Segment Forecast to 2034


Companion Animal Diagnostics Market Introduction and Overview

According to SPER market research, ‘Global Companion Animal Diagnostics Market Size- By Product, By Technology, By Application, By Animal, By End User – Regional Outlook, Competitive Strategies and Segment Forecast to 2033’ state that the Global Companion Animal Diagnostics Market is predicted to reach 8.4 billion by 2034 with a CAGR of 9.05%.

A molecular diagnostic method for identifying chronic illnesses in companion animals is called companion animal diagnostics. Many chronic diseases in animals are believed to be best diagnosed and defined by companion animal diagnostics. Disorders are identified using a variety of diagnostic techniques, such as uranalysis, clinical biochemistry, immunodiagnostic testing, and molecular diagnostics.

Restraints: There is a severe lack of qualified veterinarians and pathologists in the worldwide animal healthcare industry, especially in developing regions like Asia Pacific and Latin America. Despite a significant demand for veterinary services, nations like China and Brazil lack skilled veterinarians. This disparity impedes the industry’s expansion and has an impact on the uptake of cutting-edge diagnostic tools, which are crucial for companion animals. Another obstacle is the high cost of diagnostic tests, which is particularly problematic in developing nations because many clinics cannot afford this technology.

Scope of the report:

Report Metric Details
Market size available for years 2021-2034
Base year considered 2024
Forecast period 2025-2034
Segments covered By Product, By Technology, By Application, By Animal, By End User

Regions covered

North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa

Companies Covered

IDEXX, Zoetis Services LLC, Mars, Incorporated, FUJIFILM Corporation, bioMérieux, Thermo Fisher Scientific Inc, Virbac, Neogen Corporation, INDICAL BIOSCIENCE GmbH, IDvet, Randox Laboratories Ltd, Shenzhen Mindray Animal Medical Technology Co, LTD, Bionote USA Inc, Boule, EUROIMMUN Medizinische Labordiagnostika AG, Biopanda Reagents Ltd, Nova Biomedical.

Companion Animal Diagnostics Market Segmentation:

By Product: Based on the Product, Global Companion Animal Diagnostics Market is segmented as; Consumables, Instruments.

By Technology: Based on the Technology, Global Companion Animal Diagnostics Market is segmented as; Clinical Biochemistry, Immunodiagnostics, Hematology, Urinalysis, Molecular Diagnostics, Other Companion Animal Diagnostics Technologies.

By Animal: Based on the Animal, Global Companion Animal Diagnostics Market is segmented as; Dogs, Cats, Horses and Other Companion Animals.

By Application: Based on the Application, Global Companion Animal Diagnostics Market is segmented as; Clinical Pathology, Bacteriology, Virology, Parasitology

By End User: Based on the End User, Global Companion Animal Diagnostics Market is segmented as; Diagnostics Laboratories, Veterinary Hospitals and Clinics, Research Institutes and Universities, Home-Care Settings.


1. Introduction
1.1. Scope of the report
1.2. Market segment analysis
2. Research Methodology
2.1. Research data source
2.1.1. Secondary Data
2.1.2. Primary Data
2.1.3. SPERs internal database
2.1.4. Premium insight from KOLs
2.2. Market size estimation
2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation
3. Executive Summary
4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunities
4.1.4. Challenges
5. Market variable and outlook
5.1. SWOT Analysis
5.1.1. Strengths
5.1.2. Weaknesses
5.1.3. Opportunities
5.1.4. Threats
5.2. PESTEL Analysis
5.2.1. Political Landscape
5.2.2. Economic Landscape
5.2.3. Social Landscape
5.2.4. Technological Landscape
5.2.5. Environmental Landscape
5.2.6. Legal Landscape
5.3. PORTERs Five Forces
5.3.1. Bargaining power of suppliers
5.3.2. Bargaining power of buyers
5.3.3. Threat of Substitute
5.3.4. Threat of new entrant
5.3.5. Competitive rivalry
5.4. Heat Map Analysis
6. Competitive Landscape
6.1. Global Companion Animal Diagnostics Market Manufacturing Base Distribution, Sales Area, Product Type
6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Companion Animal Diagnostics Market
7. Global Companion Animal Diagnostics Market, By Product (USD Million) 2021-2034
7.1. Consumables
7.2. Instruments
8. Global Companion Animal Diagnostics Market, By Technology (USD Million) 2021-2034
8.1. Clinical Biochemistry
8.2. Immunodiagnostics
8.3. Hematology
8.4. Urinalysis
8.5. Molecular Diagnostics
9. Global Companion Animal Diagnostics Market, By Application (USD Million) 2021-2034
9.1. Clinical Pathology
9.2. Bacteriology
9.3. Virology
9.4. Parasitology
9.5. Others Applications
10. Global Companion Animal Diagnostics Market, By Animal (USD Million) 2021-2034
10.1. Dogs
10.2. Cats
10.3. Horses
10.4. Other Companion Animals
11. Global Companion Animal Diagnostics Market, By End User (USD Million) 2021-2034
11.1. Diagnostic Laboratories
11.2. Veterinary Hospitals and Clinics
11.3. Research Institutes & Universities
11.4. Home-care Settings
12. Global Companion Animal Diagnostics Market (USD Million) 2021-2034
12.1. Global Companion Animal Diagnostics Market Size and Market Share
13. Global Companion Animal Diagnostics Market, By Region (USD Million) 2021-2034
13.1. Asia-Pacific
13.1.1. Australia
13.1.2. China
13.1.3. India
13.1.4. Japan
13.1.5. South Korea
13.1.6. Rest of Asia-Pacific
13.2. Europe
13.2.1. France
13.2.2. Germany
13.2.3. Italy
13.2.4. Spain
13.2.5. United Kingdom
13.2.6. Rest of Europe
13.3. Middle East and Africa
13.3.1. Kingdom of Saudi Arabia
13.3.2. United Arab Emirates
13.3.3. Qatar
13.3.4. South Africa
13.3.5. Egypt
13.3.6. Morocco
13.3.7. Nigeria
13.3.8. Rest of Middle-East and Africa
13.4. North America
13.4.1. Canada
13.4.2. Mexico
13.4.3. United States
13.5. Latin America
13.5.1. Argentina
13.5.2. Brazil
13.5.3. Rest of Latin America
14. Company Profile
14.1. IDEXX
14.1.1. Company details
14.1.2. Financial outlook
14.1.3. Product summary
14.1.4. Recent developments
14.2. Zoetis Services LLC
14.2.1. Company details
14.2.2. Financial outlook
14.2.3. Product summary
14.2.4. Recent developments
14.3. Mars, Incorporated
14.3.1. Company details
14.3.2. Financial outlook
14.3.3. Product summary
14.3.4. Recent developments
14.4. FUJIFILM Corporation
14.4.1. Company details
14.4.2. Financial outlook
14.4.3. Product summary
14.4.4. Recent developments
14.5. bioMerieux
14.5.1. Company details
14.5.2. Financial outlook
14.5.3. Product summary
14.5.4. Recent developments
14.6. Thermo Fisher Scientific Inc
14.6.1. Company details
14.6.2. Financial outlook
14.6.3. Product summary
14.6.4. Recent developments
14.7. Virbac
14.7.1. Company details
14.7.2. Financial outlook
14.7.3. Product summary
14.7.4. Recent developments
14.8. Neogen Corporation
14.8.1. Company details
14.8.2. Financial outlook
14.8.3. Product summary
14.8.4. Recent developments
14.9. INDICAL BIOSCIENCE GmbH
14.9.1. Company details
14.9.2. Financial outlook
14.9.3. Product summary
14.9.4. Recent developments
14.10. IDvet
14.10.1. Company details
14.10.2. Financial outlook
14.10.3. Product summary
14.10.4. Recent developments
14.11. Randox Laboratories Ltd
14.11.1. Company details
14.11.2. Financial outlook
14.11.3. Product summary
14.11.4. Recent developments
14.12. Shenzhen Mindray Animal Medical Technology Co, LTD
14.12.1. Company details
14.12.2. Financial outlook
14.12.3. Product summary
14.12.4. Recent developments
14.13. Bionote USA Inc
14.13.1. Company details
14.13.2. Financial outlook
14.13.3. Product summary
14.13.4. Recent developments
14.14. Boule
14.14.1. Company details
14.14.2. Financial outlook
14.14.3. Product summary
14.14.4. Recent developments
14.15. EUROIMMUN Medizinische Labordiagnostika AG
14.15.1. Company details
14.15.2. Financial outlook
14.15.3. Product summary
14.15.4. Recent developments
14.16. Biopanda Reagents Ltd
14.16.1. Company details
14.16.2. Financial outlook
14.16.3. Product summary
14.16.4. Recent developments
14.17. Nova Biomedical
14.17.1. Company details
14.17.2. Financial outlook
14.17.3. Product summary
14.17.4. Recent developments
14.18. Others
15. Conclusion
16. List of Abbreviations
17. Reference Links

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings